TOMI Environmental Solutions Calls Upon Cruise Lines to Improve Decontamination and Adopt Hospital-Grade Technology Like SteraMist to Safeguard Passengers and Crew
Rhea-AI Summary
TOMI Environmental Solutions (NASDAQ:TOMZ) on Dec. 15, 2025 urged cruise lines to adopt hospital-grade decontamination technology such as SteraMist to improve passenger and crew safety. TOMI highlighted cruise ships as concentrated, high‑risk environments for pathogens like Norovirus and Legionella and referenced recent outbreaks to argue for proactive, comprehensive disinfection beyond traditional cleaning.
The release says SteraMist can treat high‑risk areas (dining, crew quarters, clinics, children’s play areas, outdoor furniture), enable faster outbreak containment, reduce downtime, and increase passenger confidence. TOMI invites cruise operators and the public to partner with the company and provides contact info for assistance.
Positive
- None.
Negative
- None.
News Market Reaction – TOMZ
In the Dec 15 session, TOMZ declined 5.06%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 04 | Investor conference | Neutral | -0.3% | Sidoti Year End Investor Conference presentation on SteraMist and BIT platform. |
| Nov 26 | Commercial pipeline update | Positive | +2.5% | Announced ~$3M custom integration pipeline and 10 active SteraMist projects. |
| Nov 17 | Shelf & ELOC financing | Negative | -8.6% | Filed $50M S-3 shelf and $20M equity line with Hudson Global Ventures. |
| Nov 14 | Q3 2025 earnings | Negative | -8.6% | Reported Q3 revenue jump but net loss and weaker year-to-date sales and losses. |
| Nov 10 | Earnings call notice | Neutral | +2.3% | Announced timing and access details for Q3 2025 results conference call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news skewed toward financing, compliance, and growth updates; larger negative moves followed dilution/financing headlines, while operational or conference items saw smaller, mixed reactions.
Over the last month, TOMZ has combined growth messaging with balance sheet actions. On Nov 14, Q3 2025 results showed sharply higher sequential revenue but ongoing losses. Shortly after, the company filed a $50M S‑3 shelf and disclosed a $20M equity line, which coincided with -8.59% moves. A $3M life sciences integration pipeline on Nov 26 and a Sidoti conference appearance on Dec 4 emphasized commercialization of SteraMist. Today’s call for cruise-line adoption fits this ongoing effort to broaden use cases for the platform.
Key Terms
norovirus medical
legionella medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
FREDERICK, Md., Dec. 15, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, is calling upon cruise lines to improve decontamination and adopt hospital-grade technology like SteraMist as a compromise-free standard for advanced maritime decontamination.
“The question should no longer be if cruise lines can prevent health outbreaks, but how often and how comprehensively they are utilizing hospital-grade disinfection technology like SteraMist to safeguard passengers and crew,” said Dr. Halden Shane, CEO of TOMI. “Cruise ships are highly concentrated, high-risk environments with limited options for isolation and evacuation, creating the perfect hotbed for pathogens such as Norovirus and Legionella. These microbes spread rapidly through close quarters and shared water systems, making their way into new countries and placing entire populations at risk of foreign microbial infections. This urgency is underscored by recent reports, including a Norovirus outbreak on an AIDA Cruises vessel that sickened over 100 passengers—the 21st such incident tracked by the CDC this year alone."
"The expectations of the post-pandemic traveler have fundamentally changed," continued Dr. Halden Shane. "Passengers deserve the assurance that every environment—from the main dining room and buffet line to the crew quarters and the ship’s clinic—is treated with the highest efficacy disinfection technology available."
The application of SteraMist provides solutions for critical vessel areas often overlooked by traditional cleaning methods including public dining and entertainment areas, crew health, high-risk and children’s areas, such as the on-board clinic, operating rooms, children’s play structures, and even outdoor lounge chairs. SteraMist enables proactive outbreak management, allowing for the quick and thorough disinfection of affected spaces to minimize downtime and contain any potential spread far more effectively than traditional methods.
"It is time to move beyond reactive cleaning and embrace proactive, preventative decontamination," concluded Dr. Shane. "The value proposition for cruise lines is clear: greater passenger confidence, reduced operational risk from outbreaks, and a powerful marketing advantage. SteraMist can protect everyone from the captain to the vacationing family, while improving demand and confidence of travelers to purchase cruise line trips. We call upon the cruise industry and the public to partner with us in advocating for the global adoption of improved disinfection such as SteraMist, as we remain committed to innovating for a safer world.”
TOMI encourages you to contact them directly to assist with this mission. Please reach out via email at info@tomimist.com or call 800-525-1698.
About TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.
Forward-Looking Statements
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements regarding the application of TOMI products in cruise lines and potential revenue opportunities. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
